Retraction notices

Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis

Type
Correction
Notice date
1/4/2021 0:00
Journal
The Journal of Biological Chemistry
Publisher
Elsevier
Notice DOI
10.1074/jbc.aac120.016502
Original paper DOI
10.1074/jbc.m113.477216

Reasons